Ticker Details
Omeros Corporation Omeros Corp is a biopharmaceutical company. It focuses on research and development of small-molecule and protein therapeutics to treat inflammation, coagulopathies, and disorders of the central nervous system and sells Omidria for cataract surgeries.
IPO Date:	October 8, 2009
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$857.47M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.31 | 3.19%
Avg Daily Range (30 D):	$0.28 | 2.50%
Avg Daily Range (90 D):	$0.38 | 3.15%

Institutional Daily Volume
Avg Daily Volume:	.59M
Avg Daily Volume (30 D):	.9M
Avg Daily Volume (90 D):	1.75M

Trade Size
Avg Trade Size (Sh.):	132
Avg Trade Size (Sh.) (30 D):	67
Avg Trade Size (Sh.) (90 D):	87

Institutional Trades
Total Institutional Trades:	1,357
Avg Institutional Trade:	$1.45M
Avg Institutional Trade (30 D):	$1.23M
Avg Institutional Trade (90 D):	$1.34M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.51M
Avg Closing Trade (30 D):	$1.27M
Avg Closing Trade (90 D):	$1.41M
Avg Closing Volume:	123.29K

News

Dec 24, 2025 @ 10:22 PM Why Omeros Stock Skyrocketed Today Source: Eric Volkman

Nov 5, 2025 @ 6:30 AM Novo Nordisk's sales increased by 12% in Danish kr... Source: Novo Nordisk

Oct 23, 2025 @ 12:35 PM Breakout Momentum Plays You Need to Know About Source: Nathan Reiff

Oct 22, 2025 @ 5:00 PM Complement 3 Glomerulopathy Market Poised for Phen... Source: Delveinsight

Apr 1, 2024 @ 7:35 AM Investor Sentiment Edges Lower, US Stocks Record G... Source: Avi Kapoor

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.05	$1.42	$-.05
Diluted EPS	$-.05	$1.42	$-.05
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-3.35M	$86.45M	$-3.35M
Operating Income / Loss	$-122.8M	$-29.08M	$-122.8M
Cost of Revenue
Net Cash Flow	$6.26M	$7.27M	$6.26M
PE Ratio

Splits
Oct 02, 2009	25:49